Clinical Trial Update: Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial update evaluating a combination of pegylated interferon and entecavir for chronic hepatitis B; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: UNKNOWN